Search
Now showing items 11-15 of 15
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Concentrations of IL-17 and autoantibodies in sera of patients with primary Sjogren's syndrome
(BMJ Publishing Group, London, 2007)
Methods of assessment of iodine status in humans: a systematic review
(Oxford Univ Press, Oxford, 2009)
Background: Biomarkers of iodine status are required to study iodine deficiency disorders in different parts of the world and to evaluate the effects of fortification strategies. Objective: The objective was to assess the ...
Plasma fatty acid composition in overweight patients with hypertriglyceridemia
(Elsevier Ireland Ltd, Clare, 2006)
Erythrocyte fatty acid composition in obese patients with hyperlipidemia
(Elsevier Ireland Ltd, Clare, 2006)